Literature DB >> 25005685

Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses.

Michael P Waalkes1, Wei Qu, Erik J Tokar, Grace E Kissling, Darlene Dixon.   

Abstract

In mice, inorganic arsenic in the drinking water in the parts per million range via the dam during in utero life or with whole-life exposure is a multi-site carcinogen in the offspring. However, human arsenic exposure is typically in the parts per billion (ppb) range. Thus, we studied "whole-life" inorganic arsenic carcinogenesis in mice at levels more relevant to humans. Breeder male and female CD1 mice were exposed to 0, 50, 500 or 5,000 ppb arsenic (as sodium arsenite) in the drinking water for 3 weeks prior to breeding, during pregnancy and lactation, and after weaning (at week 3) groups of male and female offspring (initial n = 40) were exposed for up to 2 years. Tumors were assessed in these offspring. Arsenic exposure had no effect on pregnant dam weights or water consumption, litter size, offspring birthweight or weight at weaning compared to control. In male offspring mice, arsenic exposure increased (p < 0.05) bronchiolo-alveolar tumor (adenoma or carcinoma) incidence at 50-ppb group (51 %) and 500-ppb group (54 %), but not at 5,000-ppb group (28 %) compared to control (22 %). These arsenic-induced bronchiolo-alveolar tumors included increased (p < 0.05) carcinoma at 50-ppb group (27 %) compared to controls (8 %). An increase (p < 0.05) in lung adenoma (25 %) in the 50-ppb group compared to control (11 %) occurred in female offspring. Thus, in CD1 mice whole-life arsenic exposure induced lung tumors at human-relevant doses (i.e., 50 and 500 ppb).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005685      PMCID: PMC4130362          DOI: 10.1007/s00204-014-1305-8

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  32 in total

1.  Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice.

Authors:  Bing Liu; Shangha Pan; Xuesong Dong; Haiquan Qiao; Hongchi Jiang; Geoffrey W Krissansen; Xueying Sun
Journal:  Cancer Sci       Date:  2006-07       Impact factor: 6.716

2.  Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration.

Authors:  Chandrashekhar D Kamat; Dixy E Green; Susan Curilla; Linda Warnke; Joshua W Hamilton; Stefan Sturup; Callie Clark; Michael A Ihnat
Journal:  Toxicol Sci       Date:  2005-05-11       Impact factor: 4.849

Review 3.  In utero and early life arsenic exposure in relation to long-term health and disease.

Authors:  Shohreh F Farzan; Margaret R Karagas; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2013-07-13       Impact factor: 4.219

4.  Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment.

Authors:  Michael P Waalkes; Jie Liu; Jerrold M Ward; Douglas A Powell; Bhalchandra A Diwan
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

5.  Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice.

Authors:  Michael P Waalkes; Jerrold M Ward; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2003-01-01       Impact factor: 4.219

6.  Arsenic stimulates angiogenesis and tumorigenesis in vivo.

Authors:  Nicole V Soucy; Michael A Ihnat; Chandrashekhar D Kamat; Linda Hess; Mark J Post; Linda R Klei; Callie Clark; Aaron Barchowsky
Journal:  Toxicol Sci       Date:  2003-09-11       Impact factor: 4.849

7.  Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers.

Authors:  Michael P Waalkes; Jerrold M Ward; Bhalchandra A Diwan
Journal:  Carcinogenesis       Date:  2003-09-26       Impact factor: 4.944

Review 8.  The evolving use of arsenic in pharmacotherapy of malignant disease.

Authors:  Athena Kritharis; Thomas P Bradley; Daniel R Budman
Journal:  Ann Hematol       Date:  2013-03-15       Impact factor: 3.673

9.  Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain.

Authors:  Jack E Bodwell; Lauren A Kingsley; Joshua W Hamilton
Journal:  Chem Res Toxicol       Date:  2004-08       Impact factor: 3.739

10.  Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood.

Authors:  Allan H Smith; Guillermo Marshall; Yan Yuan; Catterina Ferreccio; Jane Liaw; Ondine von Ehrenstein; Craig Steinmaus; Michael N Bates; Steve Selvin
Journal:  Environ Health Perspect       Date:  2006-08       Impact factor: 9.031

View more
  24 in total

Review 1.  State of the science review of the health effects of inorganic arsenic: Perspectives for future research.

Authors:  Paul B Tchounwou; Clement G Yedjou; Udensi K Udensi; Maricica Pacurari; Jacqueline J Stevens; Anita K Patlolla; Felicite Noubissi; Sanjay Kumar
Journal:  Environ Toxicol       Date:  2018-12-04       Impact factor: 4.119

2.  In utero arsenic exposure and epigenome-wide associations in placenta, umbilical artery, and human umbilical vein endothelial cells.

Authors:  Andres Cardenas; E Andres Houseman; Andrea A Baccarelli; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mostofa; Robert O Wright; David C Christiani; Molly L Kile
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

3.  Cellular and Molecular Effects of Prolonged Low-Level Sodium Arsenite Exposure on Human Hepatic HepaRG Cells.

Authors:  Kostiantyn Dreval; Volodymyr Tryndyak; Iryna Kindrat; Nathan C Twaddle; Orish Ebere Orisakwe; Thilak K Mudalige; Frederick A Beland; Daniel R Doerge; Igor P Pogribny
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

4.  Response to letter to the editor by Cohen et al. (2014) "Re: Waalkes et al.: Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses, Arch Toxicol, 2014".

Authors:  Michael P Waalkes; Wei Qu; Erik J Tokar; Grace E Kissling; Darlene Dixon
Journal:  Arch Toxicol       Date:  2014-09-25       Impact factor: 5.153

5.  In utero exposure to arsenite contributes to metabolic and reproductive dysfunction in male offspring of CD-1 mice.

Authors:  Karina F Rodriguez; Namya Mellouk; Erica K Ungewitter; Barbara Nicol; Chang Liu; Paula R Brown; Cynthia J Willson; Humphrey H-C Yao
Journal:  Reprod Toxicol       Date:  2020-05-17       Impact factor: 3.143

6.  The Influence of Feed and Drinking Water on Terrestrial Animal Research and Study Replicability.

Authors:  David M Kurtz; William P Feeney
Journal:  ILAR J       Date:  2020-10-19

7.  Elevated Arsenic and Lead Concentrations in Natural Healing Clay Applied Topically as a Treatment for Ulcerative Dermatitis in Mice.

Authors:  Tanya E Whiteside; Wei Qu; Michael J DeVito; Sukhdev S Brar; Karen D Bradham; Clay M Nelson; Gregory S Travlos; Grace E Kissling; David M Kurtz
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-02-14       Impact factor: 1.232

8.  Multi-generational impacts of arsenic exposure on genome-wide DNA methylation and the implications for arsenic-induced skin lesions.

Authors:  Xiaojuan Guo; Xushen Chen; Jie Wang; Zhiyue Liu; Daniel Gaile; Hongmei Wu; Guan Yu; Guangyun Mao; Zuopeng Yang; Zhen Di; Xiuqing Guo; Li Cao; Peiye Chang; Binxian Kang; Jinyu Chen; Wen Gao; Xuefeng Ren
Journal:  Environ Int       Date:  2018-07-05       Impact factor: 9.621

Review 9.  Impact of prenatal arsenic exposure on chronic adult diseases.

Authors:  Jamie L Young; Lu Cai; J Christopher States
Journal:  Syst Biol Reprod Med       Date:  2018-06-06       Impact factor: 3.061

Review 10.  Metals and molecular carcinogenesis.

Authors:  Yusha Zhu; Max Costa
Journal:  Carcinogenesis       Date:  2020-09-24       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.